Table 3.
Comparison of DEX dosage-related adverse effects.
| All-patient population | Propensity-matched population | |||||
|---|---|---|---|---|---|---|
| Low-dose group (n = 45) (%) | High-dose group (n = 47) (%) | P-value | Low-dose group (n = 24) (%) | High-dose group (n = 24) (%) | P-value | |
| Nausea | ||||||
| Grade 1/2 | 31.1 | 25.5 | 0.65 | 29.2 | 33.3 | 1.00 |
| Anorexia | ||||||
| Grade 1/2 | 28.9 | 25.5 | 0.82 | 29.2 | 33.3 | 1.00 |
| Fatigue | ||||||
| Grade 1/2 | 33.3 | 44.7 | 0.29 | 41.7 | 54.2 | 0.56 |
| FN | ||||||
| Grade 3 | 28.9 | 23.4 | 0.64 | 33.3 | 20.8 | 0.52 |
| Insomnia | ||||||
| Grade 1/2 | 40.9 | 36.2 | 0.67 | 41.7 | 45.8 | 1.00 |
FN febrile neutropenia.